GenesisCare North Shore (Oncology)

St Leonards 2065

2 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Gastric Cancer, Gastroesophageal Junction Cancer, Ovarian Cancer, Solid Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) — Running, not enrolling